Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (74 page)

Anasah, C., et al. In vitro genotoxicity of the West African anti-malarial herbal
Cryptolepis sanguinolenta
and its major alkaloid cryptolepine.
Toxicology
208, no. 1 (2005): 141–47.

Anonymous. Antimicrobial properties of some West African medicinal plants II. Antimicrobial activity of aqueous extracts of
Cryptolepis sanguinolenta
(Lindl.) Schlechter.
Quart. J. Crude Du Res
17, no. 2 (1979): 78–80.

Anonymous. Cryptolepis: An African traditional medicine that provides hope for malaria victims.
Herbal Gram
60 (2003): 54–59, 67.

Anonymous.
Cryptolepis buchanani
. Brief profile on the website of Ayurvedic Community at
http://ayurvediccommunity.com/Botany.asp?Botname=Cryptolepis%20buchanani
(accessed December 28, 2010).

Anonymous. Review of cryptoline. On the website of
EurekaMag.com
at
http://eurekamag.com/review/c/427/cryptolepine.php
(accessed November 20, 2010).

Anonymous. Selected African botanical remedies.
http://academic.cengage.com/resource_uploads/downloads/049511541X_122179.pdf
.

Anonymous. Shyamlata. On the website of
AyurvedaConsultants.com
at http://ayurvedaconsultants.com/images/doctor/ayurveda/ayurvedic-herb-shyamlata.aspx (accessed December 28, 2010).

Ansah, C., et al. Anxiogenic effects of an aqueous crude extract of
Cryptolepis sanguinolenta
(Periploceae) in mice.
Int J Pharmacol
4, no. 1 (2008): 20–26.

Ansah, C., et al. Cryptolepine provokes changes in the expression of cell cycle proteins in growing cells.
Am J Pharmacol Tox
4, no. 4 (2009): 177–85.

Ansah, C., et al. The popular herbal antimalarial, extract of
Cryptolepis sanguinolenta
, is potently cytotoxic.
Oxford J Life Sci Med Tox Sci
70, no. 2 (2002): 245–51.

Ansah, C., et al. Reproductive and developmental toxicity of
Cryptolepis sanguinolenta
in mice.
Res J Pharmacol
4, no. 1 (2010): 9–14.

Ansah, C., et al. Toxicological evaluation of the anti-malarial herb
Cryptolepis sanguinolenta
in rodents.
J Pharmacol Toxicol
3 (2008): 335–43.

Appiah, Alfred A. The golden roots of
Cryptolepis sanguinolenta
. In
African natural plant products: new discoveries and challenges in chemistry and quality
, ed. H. R. Juliani, J. E. Simon, and C.-T. Ho, 231–39. ACS Symposium Series 1021. American Chemical Society, 2009.

Asase, A., et al.
Medicinal plants used for the treatment of malaria in Wechiau Community Hippopotamus Sanctuary in Ghana
. Abstract of an oral presentation made at the Society for Economic Botany's 48th annual meeting, June 4–7, 2007, at Lake Forest College, Chicago, Ill.
http://econbot.org/_organization_/07_annual_meetings/meetings_by_year/2007/pdfs/abstracts/asase.pdf
.

Bakhlet, A. O., et al. Therapeutic utility, constituents and toxicity of some medicinal plants: a review.
Vet Human Toxicol
37, no. 3 (1995): 255–58.

Banerji, J., et al. A novel route to anticonvulsant imesatins and an approach to cryptolepine, the alkaloid from
Cryptolepis
sp.
Indian J Chem
44B (2005): 426–29.

Bérangére, G., et al. Synthesis and evaluation of analogues of 10H-indol[3-2-b]-quinoline as G-quadruplex stabilizing ligands and potential inhibitors of the enzyme telomerase.
Org Biomol Chem
2 (2004): 981–88.

Bierer, D. E., et al. Antihyperglycemic activities of crytolepine analogues: an ethnobotanical lead structure isolated from
Cryptolepis sanguinolenta
.
J Med Chem
41, no. 15 (1998): 2754–64.

Bierer, D. E., et al. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from
Cryptolepis sanguinolenta
, synthesis, and in vitro and in vivo activities.
J Med Chem
41, no. 6 (1998): 894–901.

Bierer, D. E. Hypoglycemic agent from cryptolepis. U.S. Patent 5,917,052, filed September 28, 1994, and issued June 29, 1999.

Boakye-Yiadom, K., et al. Cryptolepine hydrochloride effect on
Staphylococcus aureus
.
J Pharm Sci
68, no. 12 (1979): 1510–14.

Bugyei, K. A., et al. Clinical efficacy of a tea-bag formulation of
Cryptolepis sanguinolenta
root in the treatment of acute uncomplicated falciparum malaria.
Ghana Med J
44, no. 1 (2010): 3–9.

Cimanga, K., et al. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from
Cryptolepis sanguinolenta
.
J Nat Prod
60, no. 7 (1997): 688–91.

Cimanga, K., et al. In vitro biological activities of alkaloids from
Cryptolepis sanguinolenta
.
Planta Med
62, no. 1 (1996): 22–27.

Dankwa, Kwabena. Evaluation of antimalarial activity of four (4)
Cryptolepis sanguinolenta
based herbal preparations on
Plasmodium berghei
in mice. Thesis, Kwame Nkruma University of Science and Technology (Ghana), 2006.
http://dspace.knust.edu.gh/dspace/handle/123456789/1590
.

Dassonneville, L., et al. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Eur J Pharmacol
409, no. 1 (2000): 9–18.

Gibbons, S., et al. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from
Cryptolepis sanguinolenta
.
Phytother Res
17, no. 4 (2003): 434–36.

Grycová, Lenka. Applications of NMR to study structures of natural compounds. PhD thesis, Masaryk University, 2010.
http://is.muni.cz/th/12679/prif_d/PhD_thesis_LG.pdf
.

Guittat, L., et al. Interactions of cryptolepine and neocryptolepine with unusual DNA structures.
Biochemie
85, no. 5 (2003): 535–47.

Hadden, C. E., et al. 11-isopropylcryptolepine: a novel alkaloid isolated from
Cryptolepis sanguinolenta
characterized using submicro NMR techniques.
J Nat Prod
62, no. 2 (1999): 238–40.

Humenuik, R., et al. Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives.
Oncol Res
13, no. 5 (2003): 269–77.

Iwu, Maurice M. The Associate Program on Ethnobiology, Socio-Economic Value Assessment and Community Based Conservation. Report DAMD17-99-2-9025, prepared for the U.S. Army Medical Research and Materiel Command, Fort Detrick, Md., October 2000.
http://www.dtic.mil/cgi-bin/GetTRDoc?Location=U2&doc=GetTRDoc.pdf&AD=ADA406251
.

Jansen, P. C. M., and Schmelzer, G. H.
Cryptolepis sanguinoleta
(Lindl.) Schltr. Record from Protabase database, ed. G. J. H. Grubben and O. A. Denton (PROTA: Plant Resources of Tropical Africa/Resources végétales de l'Afrique tropicale). Wageningen, Netherlands.
http://database.prota.org/search.htm
(accessed November 18, 2010).

Jaromin, A., et al. Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b] quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells.
Drug Deliv
15, no. 1 (2008): 49–56.

Jonckers, T. H., et al. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives.
J Med Chem
45, no. 16 (2002): 3497–508.

Kaul, A., et al. Immunopotentiating properties of
Cryptolepis buchanani
root extract.
Phytother Res
17, no. 10 (2003): 1140–44.

Laupattarakasem, P., et al. An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis.
J Ethnopharmacol
85, no. 2–3 (2003): 207–15.

Laupattarakasem, P., et al. In vitro and in vivo anti-inflammatory potential of
Cryptolepis buchanani
.
J Ethnopharmacol
108, no. 3 (2006): 349–54.

Luo, J., et al.
Cryptolepis sanguinolenta
: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.
Diabet Med
15, no. 5 (1998): 367–74.

Luo, J., et al. Hypoglycemic agent from cryptolepis. U.S. Patent 5,629,319, filed June 6, 1995, and issued May 13, 1997.

Maurya, et al. Pharmaceutical composition comprising extract from plant
Cryptolepis buchanani
for tea. U.S. Patent 6,548,086, filed December 18, 2001, and issued April 15, 2003.

Mills-Robertson, F. C., et al. In vitro antimicrobial activity of
Cryptolepis sanguinolenta
(Periplocaceae).
Afr J Pharm Pharmacol
3, no. 10 (2009): 476–80.

Mtshemla, Vathiswa. Synthesis of 2,3-diaryl-4-methoxyquinolines via palladium-catalyzed cross coupling reactions. Master's thesis, University of South Africa, May 2008.
http://uir.unisa.ac.za/bitstream/handle/10500/2275/dissertation.pdf?sequence=1
.

Noamesi, B. K., et al. Studies on cryptolepine.
Planta Med
48, no. 5 (1983): 48–51.

Obua, C., et al. Antimalarial activity of some plants used in traditonal medicine in Uganda.
E C Afr J Pharma Sci
5, no. 2 (2002): 1.

Olajide, O. A., et al. Anti-inflammatory properties of cryptolepine.
Phytother Res
23, no. 10 (2009): 1421–25.

Olajide, O. A., et al. Synthetic cryptolepine inhibits DNA binding of NF-kappaB.
Bioorg Med Chem
15, no. 1 (2007): 43–49.

Oluwafemi, A. J., et al. Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis.
Nat Prod Commun
4, no. 2 (2009): 193–98.

Otsyina, Hope R. Toxicological evaluation of
Cryptolepis sanguinolenta
,
Momordica charantia
and
Euphorbia hirta
in rats. Thesis, Kwame Nkruma University of Science and Technology (Ghana), 2008.
http://dspace.knust.edu.gh:8080/jspui/handle/123456789/885
.

Oyekan, A. O., et al. Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo.
Gen Pharmacol
19, no. 2 (1988): 233–37.

Pande, M., et al. Crystalization and preliminary X-ray analysis of cryptolepain, a novel glycosylated serine protease from
Cryptolepis buchanani
.
Acta Crystallogr Sect F Struct Biol Cryst Commun
63, part 2 (2006): 74–80.

Paulo, A., et al. Antiplasmodial activity of
Cryptolepis sanguinolenta
alkaloids from leaves and roots.
Planta Med
66, no. 1 (2000): 30–34.

Paulo, A., et al. Chemotaxonomic analysis of the genus
Cryptolepis
.
Biochem Syst Ecol
31, no. 2 (2003): 155–66.

Paulo, A., et al.
Cryptolepis sanguinolenta
activity against diarrhoeal bacteria.
J Ethnopharmacol
44, no. 2 (1994): 73–77.

Paulo, A., et al. In vitro antibacterial screening of
Cryptolepis sanguinolenta
alkaloids.
J Ethnopharmacol
44, no. 2 (1994): 127–30.

Paulo, A., et al. Steroidal alkaloids from
Cryptolepis obtusa
.
Phytochemistry
53, no. 3 (2000): 417–22.

Prasad, P. J. N., et al. Micropropagation of
Cryptolepis buchanani
Roem. & Schult.
Taiwania
49, no. 1 (2004): 57–65.

Rao, V. R., et al. Interactions of cryptosin with mammalian cardiac beta-adrenoceptors.
Drug Chem Toxicol
13, no. 2–3 (1990): 173–94.

Rauwald, H. W., et al.
Cryptolepis sanguinolenta
: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
Planta Med
58, no. 6 (1992): 486–88.

Sawer, I. K., et al. The effect of cryptolepine on the morphology and survival of
Escherichia coli
,
Candida albicans
and
Saccharomyces cerevisiae
.
J Appl Bacteriol
79, no. 3 (1995): 314–21.

Sawer, I. K., et al. The killing effect of cryptolepine on
Staphylococcus aureus
.
Lett Appl Microbiol
40, no. 1 (2005): 24–29.

Silva, O., et al. Antimicrobial activity of Guinea-Bissau traditional remedies.
J Ethnopharmacol
50, no. 1 (1996): 55–59.

Simon, J. E., et al. Medicinal crops of Africa. In
Issues in new crops and new uses
, ed. J. Janick and A. Whipkey, 322–31. Alexandria, Va.: ASHS Press, 2007.
http://hort.purdue.edu/newcrop/ncnu07/pdfs/simon322-331.pdf
.

Sittiwet, C., et al. Anti-bacterial activity of
Cryptolepis buchanani
aqueous extract.
Int J Biol Chem
3 (2009): 90–94.

Soh, P. N., et al. Are West African plants a source of future antimalarial drugs?
J Ethnopharmacol
114, no. 2 (2007): 130–40.

Tempesta, Michael S. The clinical efficacy of
Cryptolepis sanguinolenta
in the treatment of malaria.
Ghana Med J
44, no. 1 (2010): 1–2.

Van Miert, S., et al. In vitro inhibition of beta-haematin formation, DNA interactions, neocryptolepine derivatives.
Exp Parasitol
108, no. 3–4 (2004): 163–68.

Van Miert, S., et al. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound.
J Nat Prod
68, no. 5 (2005): 674–77.

Venkateswara, R., et al. Cryptosin, a cardenolide from the leaves of
Cryptolepis buchanani
.
Phytochemistry
28, no. 4 (1989): 1203–5.

Wright, C. W. Cryptolepine and development of new antimalarial agents.
Iran J Pharm Res (IJPR)
3, suppl. 2 (2004): 17.

Wright, C. W. Recent developments in naturally derived antimalarials: cryptolepine analogues.
J Pharm Pharmacol
59, no. 6 (2007): 899–904.